Literature DB >> 1661657

Dilator actions of arginine in human peripheral vasculature.

A Calver1, J Collier, P Vallance.   

Abstract

1. L-Arginine is the physiological precursor for the formation of endothelium-derived nitric oxide. The synthesis of nitric oxide is stereospecific: D-arginine is not a substrate for nitric oxide synthase. It is possible that the provision of excess L-arginine substrate might increase the vascular synthesis of nitric oxide. We have examined this possibility by studying the effects of local infusion of L- and D-arginine in the forearm resistance bed and the superficial dorsal hand veins of healthy subjects. 2. Drugs were either infused locally into a vein on the back of the hand and then the vein diameter was measured using a linear displacement technique, or into the brachial artery and then the forearm blood flow was measured by venous occlusion plethysmography. 3. In the superficial hand veins, L- and D-arginine free base and L- and D-arginine hydrochloride (all four preparations at a dose of 5 mumol/min) all caused a significant increase in venous diameter. The responses of the L- and D-enantiomers did not differ significantly from one another. 4. In the forearm resistance bed, L- and D-arginine free base and L- and D-arginine hydrochloride were without effect at doses of 10 and 40 mumol/min. However, at doses of 160 mumol/min all three preparations of arginine caused a significant increase in forearm blood flow compared with control values. The responses to the three preparations of arginine did not differ significantly from one another. 5. These results show that arginine in high dose is a vasodilator in both human resistance vessels and superficial veins in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661657     DOI: 10.1042/cs0810695

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

Review 1.  Nitric oxide in the human cardiovascular system--SKB lecture 1997.

Authors:  P Vallance
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

2.  Oral L-arginine supplementation has no effect on cardiovascular responses to lower body negative pressure in man.

Authors:  J M Hind; A C Doodson
Journal:  Clin Auton Res       Date:  1994-12       Impact factor: 4.435

Review 3.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

4.  Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta.

Authors:  P Dorigo; I Maragno; G Santostasi; D Fraccarollo
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque.

Authors:  D Tousoulis; G J Davies; C Tentolouris; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

6.  L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance.

Authors:  S V Baudouin; P Bath; J F Martin; R Du Bois; T W Evans
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

7.  L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.

Authors:  S M Bode-Böger; R H Böger; A Galland; D Tsikas; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

8.  Pressor, renal and endocrine effects of L-arginine in essential hypertensives.

Authors:  R Pedrinelli; M Ebel; G Catapano; G Dell'Omo; M Ducci; M Del Chicca; A Clerico
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

9.  Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells.

Authors:  Mahesh S Joshi; T Bruce Ferguson; Fruzsina K Johnson; Robert A Johnson; Sampath Parthasarathy; Jack R Lancaster
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

10.  NO-dependent and -independent elevation of plasma levels of insulin and glucose in rats by L-arginine.

Authors:  T Jun; A Wennmalm
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.